Collaboration between stakeholders and the federal government is critical to addressing underlying gaps in patient care, said Debbie Witchey, MHA, executive vice president of the Healthcare Leadership Council.
Collaboration between stakeholders and the federal government is critical to addressing underlying gaps in patient care, said Debbie Witchey, MHA, executive vice president of the Healthcare Leadership Council.
Transcript
Through your experience assisting in the creation of public-private partnerships, how vital is it for stakeholders and providers to collaborate to avoid underlying gaps in patient care?
Collaboration from my perspective is critically important, both between stakeholders, among stakeholders, but also with including the federal government in that. We’ve done a lot of work on disaster preparedness and what we’ve seen happen is the government has 1 silo where they’re working in, and then the other stakeholders are either working with them in their own sectors or sometimes they’re crossing over; but you’re trying to get medical records in a community when they’re not available, or trying to get medicines or medical supplies to people. We literally were having CEOs of healthcare entities calling their personal friends to try to get airplanes and trying to get things into people. So, what we’ve seen, particularly since Puerto Rico, is that the federal government has realized that they need to interact better and have more interaction with stakeholders in the private sector. So, we’re starting to work together—the National Academy of Medicine is working together and you’re already seeing, although we certainly haven’t had the severity of situation that we had last year, but seeing things work better–so, that’s 1 example.
Another example where I think stakeholders working together is critically important is in the opioid space. So, you can’t just address the opioid issue from a law enforcement perspective or from a healthcare perspective, but everyone really needs to come together and try to address the issue. When that started to happen through a lot of efforts both legislative and on the private sector side in the healthcare community and non-healthcare community, we’re slowly starting to see the death rate go down.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Racial Variations in Cardiovascular Outcomes Found in Hidradenitis Suppurativa Study
March 19th 2024Based on the findings, investigators acknowledged the critical need to consider racial differences when assessing patients with hidradenitis suppurativa. Health care providers should be vigilant in addressing cardiovascular risk factors in this population, recognizing and addressing racial disparities that may impact disease management.
Read More